SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-20-002054
Filing Date
2020-02-04
Accepted
2020-02-04 14:47:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64365
  Complete submission text file 0001567619-20-002054.txt   66120
Mailing Address 399 PARK AVE NEW YORK NY 10022
Business Address 399 PARK AVE NEW YORK NY 10022 2127563300
FIRST MANHATTAN CO (Filed by) CIK: 0000728083 (see all company filings)

IRS No.: 131957714 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-48710 | Film No.: 20572984
SIC: 2834 Pharmaceutical Preparations